相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Covid-19: Pathophysiology; Mechanism of Transmission and Possible Molecular Drug Target for Management
Asis Bala et al.
CURRENT MOLECULAR PHARMACOLOGY (2021)
BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of health care workers
Magali Noval Rivas et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
COVID-19 vaccines: The status and perspectives in delivery points of view
Jee Young Chung et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Epidemiological transcriptomic data supports BCG protection in viral diseases including COVID-19
Abhay Sharma
GENE (2021)
Multidrug-resistant tuberculosis patients expressing the HLA-DRB1*04 allele, and after treatment they show a low frequency of HLA-II plus monocytes and a chronic systemic inflammation
Ranferi Ocana-Guzman et al.
MICROBIAL PATHOGENESIS (2021)
COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations
Qian He et al.
FRONTIERS IN IMMUNOLOGY (2021)
Genetics Insight for COVID-19 Susceptibility and Severity: A Review
Ingrid Fricke-Galindo et al.
FRONTIERS IN IMMUNOLOGY (2021)
SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation
Lucy G. Thorne et al.
EMBO JOURNAL (2021)
COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials
Wenping Gong et al.
EXPERT REVIEW OF VACCINES (2021)
Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients
Cristina Bergamaschi et al.
CELL REPORTS (2021)
Neutralizing Antibodies Titers and Side Effects in Response to BNT162b2 Vaccine in Healthcare Workers with and without Prior SARS-CoV-2 Infection
Jose Javier Morales-Nunez et al.
VACCINES (2021)
Age-dependent Immune Response to the Biontech/Pfizer BNT162b2 Coronavirus Disease 2019 Vaccination
Lisa Mueller et al.
CLINICAL INFECTIOUS DISEASES (2021)
Effects of interleukin-2 in immunostimulation and immunosuppression
Jonathan G. Pol et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Licensed Bacille Calmette-Guerin (BCG) formulations differ markedly in bacterial viability, RNA content and innate immune activation
Asimenia Angelidou et al.
VACCINE (2020)
Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review
Esteban Ortiz-Prado et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2020)
Strong homology between SARS-CoV-2 envelope protein and a Mycobacterium sp. antigen allows rapid diagnosis of Mycobacterial infections and may provide specific anti-SARS-CoV-2 immunity via the BCG vaccine
Gerard Nuovo et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2020)
Mandated Bacillus Calmette-Guerin (BCG) vaccination predicts flattened curves for the spread of COVID-19
Martha K. Berg et al.
SCIENCE ADVANCES (2020)
Significantly Improved COVID-19 Outcomes in Countries with Higher BCG Vaccination Coverage: A Multivariable Analysis
Danielle Klinger et al.
VACCINES (2020)
A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction
Chee Wah Tan et al.
NATURE BIOTECHNOLOGY (2020)
Cytokine storm induced by SARS-CoV-2
Peipei Song et al.
CLINICA CHIMICA ACTA (2020)
Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy
Mahesh Jayaweera et al.
ENVIRONMENTAL RESEARCH (2020)
BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis
Yusuke Tomita et al.
VACCINE (2020)
BCG vaccine: a hope to control COVID-19 pandemic amid crisis
Yashpal Singh Malik et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines
Katie L. Flanagan et al.
FRONTIERS IN IMMUNOLOGY (2020)
The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins
Carina Conceicao et al.
PLOS BIOLOGY (2020)
Protection against SARS-CoV-2 by BCG vaccination is not supported by epidemiological analyses
Janine Hensel et al.
SCIENTIFIC REPORTS (2020)
CIITA-Driven MHC Class II Expressing Tumor Cells as Antigen Presenting Cell Performers: Toward the Construction of an Optimal Anti-tumor Vaccine
Roberto S. Accolla et al.
FRONTIERS IN IMMUNOLOGY (2019)
Characterization of immune responses of human PBMCs infected with Mycobacterium tuberculosis H37Ra: Impact of donor declared BCG vaccination history on immune responses and M. tuberculosis growth
Sudha Bhavanam et al.
PLOS ONE (2018)
Back to the Future: Lessons Learned From the 1918 Influenza Pandemic
Kirsty R. Short et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2018)
BCG Vaccination Enhances the Immunogenicity of Subsequent Influenza Vaccination in Healthy Volunteers: A Randomized, Placebo-Controlled Pilot Study
Jenneke Leentjens et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Revaccination of Cattle with Bacille Calmette-Guerin Two Years after First Vaccination when Immunity Has Waned, Boosted Protection against Challenge with Mycobacterium bovis
Natalie A. Parlane et al.
PLOS ONE (2014)
Autophagy Controls BCG-Induced Trained Immunity and the Response to Intravesical BCG Therapy for Bladder Cancer
Kathrin Buffen et al.
PLOS PATHOGENS (2014)
Making wider use of the world's most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered
Christopher Dye
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2013)
Role of bacillus Calmette-Guerin in the treatment of advanced melanoma
John H. Stewart et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2011)
Immunity and ageing in man
Graham Pawelec
EXPERIMENTAL GERONTOLOGY (2006)